Tao Yang

crossMoDA challenge: Evolution of cross-modality domain adaptation techniques for vestibular schwannoma and cochlea segmentation from 2021 to 2023

Navodini Wijethilake, Reuben Dorent, Marina Ivory, Aaron Kujawa et autres

The cross-Modality Domain Adaptation (crossMoDA) challenge series, initiated in 2021 in conjunction with the International Conference on Medical Image Computing and Computer Assisted Intervention (MICCAI), focuses on unsupervised cross-modality segmentation, learning from contrast-enhanced T1 (ceT1) and transferring to T2 MRI. The task …

gb, us, nl, cn, kr, fr, sg, ae, jp, ec, de (code pays fourni par la source)

Electroacupuncture at combined acupoints GV20/ST36/GB34 regulates BDNF/TrkB-mediated synaptic remodeling and alleviates post-stroke sensorimotor deficits in male rats

Lina Ma, Tao Yang, Yunfeng Zhou

OBJECTIVE: This study investigated whether electroacupuncture (EA) at combined acupoints GV20/ST36/GB34 improves post‑stroke sensorimotor deficits in male rats, with a focus on synaptic plasticity and glial cell‑mediated neuroinflammation. METHODS: A transient right middle cerebral artery occlusion (MCAO) stroke model was successfully established …

cn (code pays fourni par la source)

Hyperglycemia during ICI Therapy: etiology, risk factors, and survival outcome

Min Shen, Xinpan Wang, Tianyu Gao, Jiang Yin et autres

cn (code pays fourni par la source)

Tailoring the performance of 3D printed TPU/GNPs flexible strain sensor with segregated structure via printing parameter optimization and microwave sintering post-processing

Tao Yang, Jiewei Hu, Zheng Yan, Jie Zhang

fr (code pays fourni par la source)

Synergistic peroxidase-like catalysis and photothermal effect in a polyoxomolybdate@Fe-polydopamine composite for enhanced antibacterial activity

Jing Dong, Tao Yang, Limin Qiao, Yuchun Han et autres

cn (code pays fourni par la source)

Discovery of 2-(methylamino)-5,6,7,8-tetrahydropyrido[4,3-d] pyrimidine derivatives as novel HsClpP activators for multiple myeloma therapy

Xiang Liu, Jinglong Gu, Yan Liu, Hong Liu et autres

cn (code pays fourni par la source)

Correction to “Rational Design of a Novel Class of Human ClpP Agonists through Ring-Opening Strategy with Enhanced Antileukemia Activity”

Xinrong Xiang, Zhengyi Dai, Baozhu Luo, Ninglin Zhao et autres

Reinforced SEBS-Based Thermoplastic Elastomers Modified by Electron Beam Irradiation

Wentong Gao, Wei Cao, Tao Yang, Yu Hui et autres

cn (code pays fourni par la source)

Correction: Is pulmonary vascular remodeling an intermediate link between hyperglycemia and adverse outcomes in patients with idiopathic pulmonary arterial hypertension? Insights from a multi-center cohort study

Sicheng Zhang, Luyang Gao, Sicong Li, Manqing Luo et autres

cn (code pays fourni par la source)

1183 HX111, a FIC OX40-mAb-VC-MMAE ADC for the treatment of lymphoma

Tao Yang, Hang Ke, Feiyu Peng, Jialin Li et autres

Background OX40 (TNFR4) is an immunostimulatory receptor expressed in activated T-cells. The OX40-OX40L (ligand of OX40) interaction plays a crucial role in the enhancement of T-cell proliferation, survival and cytokine production. OX40-mAbs were widely tested for immunotherapy in solid tumors (agonist), and …

cn (code pays fourni par la source)

1184 Exploration of sarcoma-associated OX40-expression using HX111, a novel FIC OX40-MaB-VC-MMAE-ADC, to treat OX40+ sarcoma

Lu Xie, Tao Yang, Yuhang Wang, Zihan Xu et autres

Background Sarcomas are a diverse group of malignant mesenchymal tumors of varying histopathology and treatment responsiveness (mainly radiation/chemotherapies), including many with poor prognosis and being unmet medical needs. Tumor necrosis factor receptor superfamily member 4 (TNFR4), or OX40, is an immunostimulatory receptor …

cn (code pays fourni par la source)

Diabetes heterogeneity beyond 3.8 years: missed risks of silent hypoglycaemia and long-term complications in the 4C study. Reply to Liu W, Deng B [letter]

Shuangyuan Wang, Xiaojing Jia, Yue Yin, Hong-Liang Lin et autres

cn, hk (code pays fourni par la source)